266 related articles for article (PubMed ID: 6755030)
1. [Evaluation of the hypotensive effect of slow-release Trasicor].
Cybulska I; Brym E
Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
[No Abstract] [Full Text] [Related]
2. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
Forrest WA; Bridgman KM; Ebbutt AF
Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
[No Abstract] [Full Text] [Related]
3. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
Forrest WA
Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
[No Abstract] [Full Text] [Related]
4. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
Forrest WA
Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
[No Abstract] [Full Text] [Related]
5. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
Gyntelberg F; Jacobsen K; Martlev A; Backer P
Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
[No Abstract] [Full Text] [Related]
6. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
Forrest WA
Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
[No Abstract] [Full Text] [Related]
7. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
Elsdon-Dew RW; Holden E
J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
[No Abstract] [Full Text] [Related]
8. A study comparing indapamide with cyclopenthiazide in geriatric patients.
Khan AU
Postgrad Med J; 1981; 57 Suppl 2():42-3. PubMed ID: 7033945
[TBL] [Abstract][Full Text] [Related]
9. The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination.
Forrest WA
J Int Med Res; 1981; 9(6):490-4. PubMed ID: 7033014
[TBL] [Abstract][Full Text] [Related]
10. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
Forrest WA
Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
[TBL] [Abstract][Full Text] [Related]
11. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
de los Rios JC; OrtÃz Feijoo J; Otero Cagide F
Prensa Med Mex; 1976; 41(7-8):210-4. PubMed ID: 796845
[No Abstract] [Full Text] [Related]
12. Comparison of the antihypertensive effects of indapamide and cyclopenthiazide.
James I; Griffith D; Davis J; Wollard M; Waddell G
Postgrad Med J; 1981; 57 Suppl 2():39-41. PubMed ID: 7322959
[TBL] [Abstract][Full Text] [Related]
13. A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K.
Ebbutt AF; Elsdon-Dew RW
J Int Med Res; 1979; 7(6):524-7. PubMed ID: 520655
[TBL] [Abstract][Full Text] [Related]
14. Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice.
Ebbut AF; Elsdon-Dew RW; Murphy JE
J Int Med Res; 1978; 6(6):494-8. PubMed ID: 720740
[TBL] [Abstract][Full Text] [Related]
15. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
[TBL] [Abstract][Full Text] [Related]
16. Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.
Levenstein JH
S Afr Med J; 1981 Jun; 59(25):893-9. PubMed ID: 7015537
[TBL] [Abstract][Full Text] [Related]
17. Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double-blind cross-over study with cyclopenthiazide.
Krogsgaard AR; Trap-Jensen J; Hartling O; Svendsen TL
Acta Med Scand Suppl; 1976; 602():110-3. PubMed ID: 800315
[No Abstract] [Full Text] [Related]
18. Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patients.
Forrest WA
Br J Clin Pract; 1977 Nov; 31(11):181-6. PubMed ID: 339937
[No Abstract] [Full Text] [Related]
19. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
Levenstein JH
S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
Traub YM
Arch Intern Med; 1988 Jan; 148(1):77-80. PubMed ID: 3276279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
